265 related articles for article (PubMed ID: 25826613)
1. Short-term prognostic factors for primary sclerosing cholangitis.
Watanabe T; Hirano K; Tada M; Isayama H; Mizuno S; Arizumi T; Toda N; Sugawara Y; Kokudo N; Koike K
J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):486-90. PubMed ID: 25826613
[TBL] [Abstract][Full Text] [Related]
2. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value.
de Vries EM; Wang J; Leeflang MM; Boonstra K; Weersma RK; Beuers UH; Geskus RB; Ponsioen CY
Liver Int; 2016 Dec; 36(12):1867-1875. PubMed ID: 26945698
[TBL] [Abstract][Full Text] [Related]
3. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.
Al Mamari S; Djordjevic J; Halliday JS; Chapman RW
J Hepatol; 2013 Feb; 58(2):329-34. PubMed ID: 23085647
[TBL] [Abstract][Full Text] [Related]
4. Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis.
Rupp C; Rössler A; Halibasic E; Sauer P; Weiss KH; Friedrich K; Wannhoff A; Stiehl A; Stremmel W; Trauner M; Gotthardt DN
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1292-301. PubMed ID: 25316001
[TBL] [Abstract][Full Text] [Related]
5. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
6. An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis.
Schulze J; Lenzen H; Hinrichs JB; Ringe B; Manns MP; Wacker F; Ringe KI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):192-199.e3. PubMed ID: 29775791
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Eaton JE; Nelson KM; Gossard AA; Carey EJ; Tabibian JH; Lindor KD; LaRusso NF
Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
[No Abstract] [Full Text] [Related]
8. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
Wagener G; Raffel B; Young AT; Minhaz M; Emond J
Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
[TBL] [Abstract][Full Text] [Related]
9. [The value of the baseline MELD scores, MELD-Na scores and iMELD scores in short-term prognosis in hepatitis B virus related acute-on-chronic liver failure patients].
Li C; You S; Liu H; Liu W; Wan Z; Tang G; Xin S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):539-43. PubMed ID: 25124900
[TBL] [Abstract][Full Text] [Related]
10. Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF.
Fossdal G; Mjelle AB; Wiencke K; Bjørk I; Gilja OH; Folseraas T; Karlsen TH; Rosenberg W; Giil LM; Vesterhus M
JHEP Rep; 2021 Oct; 3(5):100328. PubMed ID: 34485881
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of pediatrics end-stage liver disease or model for end-stage liver disease score in the prognosis of pediatric acute liver failure treated with artificial liver support system].
Jinhao T; Weiming C; Jing H; Jun H; Jian M; Peng S; Zhujin L; Guoping L; Yimin Z
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):280-4. PubMed ID: 26182503
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.
Liu X; Wang H; Liu X; Bridle K; Crawford D; Liang X
Pharmacol Ther; 2022 Sep; 237():108163. PubMed ID: 35271884
[TBL] [Abstract][Full Text] [Related]
13. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
14. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Murillo Perez CF; Harms MH; Lindor KD; van Buuren HR; Hirschfield GM; Corpechot C; van der Meer AJ; Feld JJ; Gulamhusein A; Lammers WJ; Ponsioen CY; Carbone M; Mason AL; Mayo MJ; Invernizzi P; Battezzati PM; Floreani A; Lleo A; Nevens F; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Thorburn D; Trivedi PJ; Verhelst X; Parés A; Janssen HLA; Hansen BE;
Am J Gastroenterol; 2020 Jul; 115(7):1066-1074. PubMed ID: 32618657
[TBL] [Abstract][Full Text] [Related]
15. High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Nyblom H; Nordlinder H; Olsson R
Liver Int; 2007 Jun; 27(5):694-9. PubMed ID: 17498256
[TBL] [Abstract][Full Text] [Related]
16. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.
Lindström L; Hultcrantz R; Boberg KM; Friis-Liby I; Bergquist A
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641
[TBL] [Abstract][Full Text] [Related]
17. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH
Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
Tang K; Shan J; Tian F; Cao W
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between model for end-stage liver disease score and prognosis in mushroom poisoning patients: a multicenter clinical study].
Cai Q; Jia Z; Liu T; Zhang C; Hui Z; Dong X; Liu Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jan; 30(1):67-71. PubMed ID: 29308761
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for disease progression of primary sclerosing cholangitis.
de Vries EM; Beuers U; Ponsioen CY
Curr Opin Gastroenterol; 2015 May; 31(3):239-46. PubMed ID: 25695934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
